Despite warnings, potentially inappropriate CNS-active medications are commonly prescribed to older adults — especially those with cognitive impairment — highlighting missed opportunities for safer ...

Vitamin D3 plus calcium offers no overall bone or muscle benefit in adolescents with perinatal HIV infection but appears to increase lumbar spine bone density in those with vitamin D insufficiency.

Distinct dietary patterns in Crohn’s and ulcerative colitis affect gut microbiota and inflammation, supporting the development of microbiome-informed dietary interventions.

Higher-dose hydroxychloroquine in systemic lupus erythematosus is tied to lower risks for some cardiac conditions and no change in stroke, kidney, or cancer risks but higher eye risk in older adults.

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.

Geographic maldistribution will be a major challenge, but increasing telehealth and advanced practice practitioners plus loan repayment programs may help.

A larger trial of trigeminal nerve stimulation in children with ADHD produce results that differ from an earlier pilot study, raising new questions about its efficacy.

Deferring systemic therapy may improve survival outcomes in carefully selected patients with metastatic renal cell carcinoma, new data suggest.

An initiative that asks surgery patients to bring their own reusable bags for belongings and a reusable water bottle decreased surgical carbon footprints, waste, and cost.

An automated SMS program embedded into TB care helped 40% of patients quit smoking; experts explore if a program might help cessation among smokers with other comorbidities.

Over 7 years, hearing aid prescription did not improve cognition but was associated with a significant reduction in the risk for dementia in older adults with moderate hearing loss.

Most patients receiving a GLP-1 receptor agonist (RA) and a biologic continue co-therapy for over a year with few treatment-related adverse events.